1-20 of 36
James G. Herman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit

Marco A. Mascarella, Tolani F. Olonisakin, Purva Rumde, Varun Vendra, Melonie A. Nance, Seungwon Kim, Mark W. Kubik, Shaum S. Sridharan, Robert L. Ferris, Moon J. Fenton, Daniel R. Clayburgh, James P. Ohr, Sonali C. Joyce, Malabika Sen, James G. Herman, Jennifer R. Grandis, Dan P. Zandberg, Umamaheswar Duvvuri
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (4): 723–730.
https://doi.org/10.1158/1078-0432.CCR-22-1768
Published: 16 February 2023
View article titled, Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit
Open the PDF for Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit in another window
Includes: Supplementary data
Journal Articles

Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer

Bin Liu, Julio Ricarte Filho, Apurva Mallisetty, Cassandra Villani, Anastasia Kottorou, Kristen Rodgers, Chen Chen, Tomoaki Ito, Kyla Holmes, Nicole Gastala, Klara Valyi-Nagy, Odile David, Ron C. Gaba, Christian Ascoli, Mary Pasquinelli, Lawrence E. Feldman, Malek G. Massad, Tza-Huei Wang, Ignacio Jusue-Torres, Enrico Benedetti, Robert A. Winn, Malcolm V. Brock, James G. Herman, Alicia Hulbert
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (16): 4339–4348.
https://doi.org/10.1158/1078-0432.CCR-19-2896
Published: 14 August 2020
View article titled, Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Open the PDF for Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract A62: Clinical translation of liquid biopsy DNA methylation biomarkers: Lessons from two systematic reviews

Kim Lommen, Zheng Feng, Cary J.G. Oberije, Alouisa J. P. van de Wetering, Selena Odeh, Alexander Koch, Maureen J. B. Aarts, Joep G. van Roermund, Leo J. Schouten, Egbert Oosterwijk, Nathalie Vaes, Ad A. M. Masclee, Beatriz Carvalho, Gerrit A. Meijer, Maurice P. Zeegers, James G. Herman, Vivianne C. Tjan-Heijnen, Veerle Melotte, Manon van Engeland, Kim Smits
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11_Supplement): A62.
https://doi.org/10.1158/1557-3265.LiqBiop20-A62
Published: 01 June 2020
View article titled, Abstract A62: Clinical translation of liquid biopsy DNA methylation biomarkers: Lessons from two systematic reviews
Journal Articles

BRCA1 Promoter Methylation Is Linked to Defective Homologous Recombination Repair and Elevated miR-155 to Disrupt Myeloid Differentiation in Myeloid Malignancies

Weijie Poh, Robert L. Dilley, Alison R. Moliterno, Jaroslaw P. Maciejewski, Keith W. Pratz, Michael A. McDevitt, James G. Herman
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (8): 2513–2522.
https://doi.org/10.1158/1078-0432.CCR-18-0179
Published: 15 April 2019
View article titled, <em>BRCA1</em> Promoter Methylation Is Linked to Defective Homologous Recombination Repair and Elevated <em>miR-155</em> to Disrupt Myeloid Differentiation in Myeloid Malignancies
Open the PDF for <em>BRCA1</em> Promoter Methylation Is Linked to Defective Homologous Recombination Repair and Elevated <em>miR-155</em> to Disrupt Myeloid Differentiation in Myeloid Malignancies in another window
Includes: Supplementary data
Journal Articles

Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study

Roisin M. Connolly, Huili Li, Rachel C. Jankowitz, Zhe Zhang, Michelle A. Rudek, Stacie C. Jeter, Shannon A. Slater, Penny Powers, Antonio C. Wolff, John H. Fetting, Adam Brufsky, Richard Piekarz, Nita Ahuja, Peter W. Laird, Hui Shen, Daniel J. Weisenberger, Leslie Cope, James G. Herman, George Somlo, Agustin A. Garcia, Peter A. Jones, Stephen B. Baylin, Nancy E. Davidson, Cynthia A. Zahnow, Vered Stearns
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11): 2691–2701.
https://doi.org/10.1158/1078-0432.CCR-16-1729
Published: 31 May 2017
View article titled, Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study
Open the PDF for Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study in another window
Includes: Supplementary data
Journal Articles

A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients

Iris J.H. van Vlodrop, Sophie C. Joosten, Tim De Meyer, Kim M. Smits, Leander Van Neste, Veerle Melotte, Marcella M.L.L. Baldewijns, Leo J. Schouten, Piet A. van den Brandt, Jana Jeschke, Joo Mi Yi, Kornel E. Schuebel, Nita Ahuja, James G. Herman, Maureen J. Aarts, Fred T. Bosman, Wim Van Criekinge, Manon van Engeland
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (8): 2006–2018.
https://doi.org/10.1158/1078-0432.CCR-16-1236
Published: 13 April 2017
View article titled, A Four-Gene Promoter Methylation Marker Panel Consisting of <em>GREM1, NEURL, LAD1,</em> and <em>NEFH</em> Predicts Survival of Clear Cell Renal Cell Cancer Patients
Open the PDF for A Four-Gene Promoter Methylation Marker Panel Consisting of <em>GREM1, NEURL, LAD1,</em> and <em>NEFH</em> Predicts Survival of Clear Cell Renal Cell Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum

Alicia Hulbert, Ignacio Jusue-Torres, Alejandro Stark, Chen Chen, Kristen Rodgers, Beverly Lee, Candace Griffin, Andrew Yang, Peng Huang, John Wrangle, Steven A. Belinsky, Tza-Huei Wang, Stephen C. Yang, Stephen B. Baylin, Malcolm V. Brock, James G. Herman
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (8): 1998–2005.
https://doi.org/10.1158/1078-0432.CCR-16-1371
Published: 13 April 2017
View article titled, Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum
Open the PDF for Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum in another window
Includes: Supplementary data
Journal Articles

A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia

Keith W. Pratz, Michelle A. Rudek, Ivana Gojo, Mark R. Litzow, Michael A. McDevitt, Jiuping Ji, Larry M. Karnitz, James G. Herman, Robert J. Kinders, B. Douglas Smith, Steven D. Gore, Hetty E. Carraway, Margaret M. Showel, Douglas E. Gladstone, Mark J. Levis, Hua-Ling Tsai, Gary Rosner, Alice Chen, Scott H. Kaufmann, Judith E. Karp
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (4): 899–907.
https://doi.org/10.1158/1078-0432.CCR-16-1274
Published: 14 February 2017
View article titled, A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia
Open the PDF for A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia in another window
Includes: Supplementary data
Journal Articles

A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid Leukemia

Ivana Gojo, Jan H. Beumer, Keith W. Pratz, Michael A. McDevitt, Maria R. Baer, Amanda L. Blackford, B. Douglas Smith, Steven D. Gore, Hetty E. Carraway, Margaret M. Showel, Mark J. Levis, Amy E. Dezern, Douglas E. Gladstone, Jiuping Jay Ji, Lihua Wang, Robert J. Kinders, Marie Pouquet, Ismail Ali-Walbi, Michelle A. Rudek, Weijie Poh, James G. Herman, Larry M. Karnitz, Scott H. Kaufmann, Alice Chen, Judith E. Karp
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (3): 697–706.
https://doi.org/10.1158/1078-0432.CCR-16-0984
Published: 31 January 2017
View article titled, A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid Leukemia
Open the PDF for A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy

Linda J.W. Bosch, Yanxin Luo, Victoria V. Lao, Petur Snaebjornsson, Geert Trooskens, Ilse Vlassenbroeck, Sandra Mongera, Weiliang Tang, Piri Welcsh, James G. Herman, Miriam Koopman, Iris D. Nagtegaal, Cornelis J.A. Punt, Wim van Criekinge, Gerrit A. Meijer, Raymond J. Monnat, Jr, Beatriz Carvalho, William M. Grady
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (18): 4612–4622.
https://doi.org/10.1158/1078-0432.CCR-15-2703
Published: 15 September 2016
View article titled, <em>WRN</em> Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy
Open the PDF for <em>WRN</em> Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy in another window
Includes: Supplementary data
Journal Articles

Poly (ADP-Ribose) Polymerase Inhibitor Hypersensitivity in Aggressive Myeloproliferative Neoplasms

Keith W. Pratz, Brian D. Koh, Anand G. Patel, Karen S. Flatten, Weijie Poh, James G. Herman, Robert Dilley, Maria I. Harrell, B. Douglas Smith, Judith E. Karp, Elizabeth M. Swisher, Michael A. McDevitt, Scott H. Kaufmann
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (15): 3894–3902.
https://doi.org/10.1158/1078-0432.CCR-15-2351
Published: 31 July 2016
View article titled, Poly (ADP-Ribose) Polymerase Inhibitor Hypersensitivity in Aggressive Myeloproliferative Neoplasms
Open the PDF for Poly (ADP-Ribose) Polymerase Inhibitor Hypersensitivity in Aggressive Myeloproliferative Neoplasms in another window
Includes: Supplementary data
Journal Articles

Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome

Ivette A.G. Deckers, Leo J. Schouten, Leander Van Neste, Iris J.H. van Vlodrop, Patricia M.M.B. Soetekouw, Marcella M.L.L. Baldewijns, Jana Jeschke, Nita Ahuja, James G. Herman, Piet A. van den Brandt, Manon van Engeland
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (15): 3492–3500.
https://doi.org/10.1158/1078-0432.CCR-14-2049
Published: 02 August 2015
View article titled, Promoter Methylation of <em>CDO1</em> Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome
Open the PDF for Promoter Methylation of <em>CDO1</em> Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome in another window
Includes: Supplementary data
Journal Articles

DNA methylation density analysis via fluorescent dye incorporation

Brian P. Keeley, Vasudev J. Bailey, Chao Yin, Katrin Passlack, Alejandro Stark, Hetty E. Carraway, Stephen B. Baylin, James G. Herman, Tza-Huei “Jeff” Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (19_Supplement): A9.
https://doi.org/10.1158/DIAG-10-A9
Published: 15 August 2014
View article titled, DNA methylation density analysis via fluorescent dye incorporation
Journal Articles

CHFR Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer

Arjen H.G. Cleven, Sarah Derks, Muriel X.G. Draht, Kim M. Smits, Veerle Melotte, Leander Van Neste, Benjamin Tournier, Valerie Jooste, Caroline Chapusot, Matty P. Weijenberg, James G. Herman, Adriaan P. de Bruïne, Manon van Engeland
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (12): 3261–3271.
https://doi.org/10.1158/1078-0432.CCR-12-3734
Published: 12 June 2014
View article titled, <em>CHFR</em> Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer
Open the PDF for <em>CHFR</em> Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Functional Identification of Cancer-Specific Methylation of CDO1, HOXA9, and TAC1 for the Diagnosis of Lung Cancer

John Wrangle, Emi Ota Machida, Ludmila Danilova, Alicia Hulbert, Noreli Franco, Wei Zhang, Sabine C. Glöckner, Mathewos Tessema, Leander Van Neste, Hariharan Easwaran, Kornel E. Schuebel, Julien Licchesi, Craig M. Hooker, Nita Ahuja, Jun Amano, Steven A. Belinsky, Stephen B. Baylin, James G. Herman, Malcolm V. Brock
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (7): 1856–1864.
https://doi.org/10.1158/1078-0432.CCR-13-2109
Published: 31 March 2014
View article titled, Functional Identification of Cancer-Specific Methylation of <em>CDO1</em>, <em>HOXA9</em>, and <em>TAC1</em> for the Diagnosis of Lung Cancer
Open the PDF for Functional Identification of Cancer-Specific Methylation of <em>CDO1</em>, <em>HOXA9</em>, and <em>TAC1</em> for the Diagnosis of Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Novel Methylation Biomarker Panel for the Early Detection of Pancreatic Cancer

Joo Mi Yi, Angela A. Guzzetta, Vasudev J. Bailey, Stephanie R. Downing, Leander Van Neste, Katherine B. Chiappinelli, Brian P. Keeley, Alejandro Stark, Alexander Herrera, Christopher Wolfgang, Emmanouil P. Pappou, Christine A. Iacobuzio-Donahue, Michael G. Goggins, James G. Herman, Tza-Huei Wang, Stephen B. Baylin, Nita Ahuja
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (23): 6544–6555.
https://doi.org/10.1158/1078-0432.CCR-12-3224
Published: 01 December 2013
View article titled, Novel Methylation Biomarker Panel for the Early Detection of Pancreatic Cancer
Open the PDF for Novel Methylation Biomarker Panel for the Early Detection of Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Frequent Inactivation of Cysteine Dioxygenase Type 1 Contributes to Survival of Breast Cancer Cells and Resistance to Anthracyclines

Jana Jeschke, Heather M. O'Hagan, Wei Zhang, Rajita Vatapalli, Marilia Freitas Calmon, Ludmila Danilova, Claudia Nelkenbrecher, Leander Van Neste, Ingrid T.G.W. Bijsmans, Manon Van Engeland, Edward Gabrielson, Kornel E. Schuebel, Andreas Winterpacht, Stephen B. Baylin, James G. Herman, Nita Ahuja
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (12): 3201–3211.
https://doi.org/10.1158/1078-0432.CCR-12-3751
Published: 13 June 2013
View article titled, Frequent Inactivation of <em>Cysteine Dioxygenase Type 1</em> Contributes to Survival of Breast Cancer Cells and Resistance to Anthracyclines
Open the PDF for Frequent Inactivation of <em>Cysteine Dioxygenase Type 1</em> Contributes to Survival of Breast Cancer Cells and Resistance to Anthracyclines in another window
Includes: Supplementary data
Journal Articles

CHFR Protein Expression Predicts Outcomes to Taxane-Based First Line Therapy in Metastatic NSCLC

Rathi N. Pillai, Seth A. Brodie, Gabriel L. Sica, You Shaojin, Ge Li, Dana C. Nickleach, Liu Yuan, Vijay A. Varma, Dacian Bonta, James G. Herman, Malcom V. Brock, Maria J.A. Ribeiro, Suresh S. Ramalingam, Taofeek K. Owonikoko, Fadlo R. Khuri, Johann C. Brandes
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (6): 1603–1611.
https://doi.org/10.1158/1078-0432.CCR-12-2995
Published: 14 March 2013
View article titled, CHFR Protein Expression Predicts Outcomes to Taxane-Based First Line Therapy in Metastatic NSCLC
Open the PDF for CHFR Protein Expression Predicts Outcomes to Taxane-Based First Line Therapy in Metastatic NSCLC in another window
Includes: Supplementary data
Journal Articles

Defining a Gene Promoter Methylation Signature in Sputum for Lung Cancer Risk Assessment

Shuguang Leng, Kieu Do, Christin M. Yingling, Maria A. Picchi, Holly J. Wolf, Timothy C. Kennedy, William J. Feser, Anna E. Baron, Wilbur A. Franklin, Malcolm V. Brock, James G. Herman, Stephen B. Baylin, Tim Byers, Christine A. Stidley, Steven A. Belinsky
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (12): 3387–3395.
https://doi.org/10.1158/1078-0432.CCR-11-3049
Published: 14 June 2012
View article titled, Defining a Gene Promoter Methylation Signature in Sputum for Lung Cancer Risk Assessment
Open the PDF for Defining a Gene Promoter Methylation Signature in Sputum for Lung Cancer Risk Assessment in another window
Includes: Supplementary data
Journal Articles

Analysis of Promoter CpG Island Hypermethylation in Cancer: Location, Location, Location!

Iris J.H. van Vlodrop, Hanneke E.C. Niessen, Sarah Derks, Marcella M.L.L. Baldewijns, Wim van Criekinge, James G. Herman, Manon van Engeland
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (13): 4225–4231.
https://doi.org/10.1158/1078-0432.CCR-10-3394
Published: 05 July 2011
View article titled, Analysis of Promoter CpG Island Hypermethylation in Cancer: Location, Location, Location!
Open the PDF for Analysis of Promoter CpG Island Hypermethylation in Cancer: Location, Location, Location! in another window